Untreated aneurysm (N=4) | FD alone (N=6) | FD + coils (N=5) | FD + ciclosporin (N=5)* | p Value | |
---|---|---|---|---|---|
Pro-MMP9 | 0.0337 | ||||
Median | 428 | 2575 | 9774 | 3159 | |
IQR | 90–1941 | 697–4917 | 7657–13562 | 1730–4150 | |
Active-MMP9 | 0.126 | ||||
Median | 483 | 2666 | 496 | 2410 | |
IQR | 251–1897 | 1066–5291 | 420–1734 | 2099–3039 | |
Pro-MMP2 | 0.779 | ||||
Median | 3250 | 4644 | 4553 | 4628 | |
IQR | 2950–6684 | 2403–7693 | 3962–5261 | 4066–8065 | |
Active-MMP2 | 0.152 | ||||
Median | 1294 | 3500 | 3653 | 3822 | |
IQR | 1143–1666 | 2684–4476 | 2186–4360 | 2670–4068 |
Kruskal—Wallis tests.
*Flow diverter + ciclosporin pro-MMP9 (N=4).
FD, flow diverter.